Evidence map›Paper›PMID 23618872›Full record

ArticleGenes & development2013

The retinoblastoma protein induces apoptosis directly at the mitochondria.

Keren I Hilgendorf, Elizaveta S Leshchiner, Simona Nedelcu, Mindy A Maynard, Eliezer Calo, Alessandra Ianari, Loren D Walensky, Jacqueline A Lees

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 125 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The significance ofFrontiers in immunology · 2024
    Review
  15. Review
  16. Review
  17. Review
  18. Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  19. Article
  20. Relevance of pRB Loss in Human Malignancies.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Keren I HilgendorfDavid H. Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Elizaveta S Leshchiner
Simona Nedelcu
Mindy A Maynard
Eliezer Calo
Alessandra Ianari
Loren D Walensky
Jacqueline A Lees
Massachusetts Institute of Technology · USDana-Farber Cancer Institute · USHarvard University · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MATTHEW G. VANDER HEIDEN · 1985 to 2026
$93.9M
YAC TECHNOLOGY IN THE REGULATION OF A LARGE GENE, BCL2R01CA050239 · NCI · WASHINGTON UNIVERSITY · PI WALENSKY, LOREN DAVID · 1989 to 2014
$4.3M
NCI NIH HHS P30 CA014051NCI NIH HHS R01 CA050239
6 · The paper itself

Abstract

The retinoblastoma protein gene RB-1 is mutated in one-third of human tumors. Its protein product, pRB (retinoblastoma protein), functions as a transcriptional coregulator in many fundamental cellular processes. Here, we report a nonnuclear role for pRB in apoptosis induction via pRB's direct participation in mitochondrial apoptosis. We uncovered this activity by finding that pRB potentiated TNFα-induced apoptosis even when translation was blocked. This proapoptotic function was highly BAX-dependent, suggesting a role in mitochondrial apoptosis, and accordingly, a fraction of endogenous pRB constitutively associated with mitochondria. Remarkably, we found that recombinant pRB was sufficient to trigger the BAX-dependent permeabilization of mitochondria or liposomes in vitro. Moreover, pRB interacted with BAX in vivo and could directly bind and conformationally activate BAX in vitro. Finally, by targeting pRB specifically to mitochondria, we generated a mutant that lacked pRB's classic nuclear roles. This mito-tagged pRB retained the ability to promote apoptosis in response to TNFα and also additional apoptotic stimuli. Most importantly, induced expression of mito-tagged pRB in Rb(-/-);p53(-/-) tumors was sufficient to block further tumor development. Together, these data establish a nontranscriptional role for pRB in direct activation of BAX and mitochondrial apoptosis in response to diverse stimuli, which is profoundly tumor-suppressive.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsApoptosisbcl-2-Associated X ProteinCell Line, TumorCell NucleusCytochromes cHumansMiceMice, NudeMice, SCIDMitochondriaProtein BindingRetinoblastoma ProteinTransplantation, HeterologousTumor Necrosis Factor-alphabcl-2-Associated X ProteinCytochromes cRetinoblastoma ProteinTumor Necrosis Factor-alphaapoptosiscancerMOMPpRBretinoblastoma protein

Identifiers

PMID23618872
PMCPMC3656319
OpenAlexW2123611122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.